Antinuclear antibodies are of considerable importance in the medical field, since - even if they are present in small quantities in many healthy individuals - they tend to increase significantly in the blood of subjects affected by systemic autoimmune diseases (CORN).
For example, virtually all patients with systemic lupus erythematosus or mixed connective tissue disease test positive for ANA.
There are several cellular components towards which the attack of antinuclear antibodies is recorded.
The term antinuclear is related to the fact that the first antibodies discovered were directed against nuclear antigens. Today, anti-nucleus antibody is an obsolete terminology, since several autoantigens-targets, clinically important in some systemic autoimmune diseases, are also localized in the cytoplasm (therefore outside the nucleus).
As anticipated, there are different types of anti-nucleus antibodies, classified according to the self-antigens towards which they are directed. Each of these antibodies has particular specificities for some autoimmune pathologies; this means that the raising of his blood values is a warning that signals the possible presence of a very specific disease.
The presence of ANA can be considered a marker of an autoimmune process and allows to rule out other conditions with similar signs and symptoms. The disease in which they are most frequently found is systemic lupus erythematosus (SLE).
;
Note
The ANA test is not used to follow or monitor the clinical course of SLE, so this test is not usually required serially.